Confident Outlook for Second Half FY 2020 from Both New and Existing Clients and Tight Expense Control Mastermind, Inc. (OTCQB: MMND), a leading vertically-integrated digital marketing company that designs, creates and activates marketing initiatives for global brands, today announced financial results for the second quarter of fiscal 2020, ended March… Read More..

Trading on Nasdaq under Ticker “ADTX” Loma Linda, CA, July 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring, today announced the closing… Read More..

- Phase 2b CONTROL study is evaluating TMB-001 (topical isotretinoin) in subtypes of rare genetic keratinization disorder - - Company also advancing Phase 2b clinical trial evaluating TMB-002 (topical rapamycin) for treatment of facial angiofibromas in tuberous sclerosis complex with 70% of trial sites now open - WOODCLIFF LAKE, N.J.,… Read More..